344 related articles for article (PubMed ID: 32086970)
1. Treatment and disease-related complications in multiple myeloma: Implications for survivorship.
Chakraborty R; Majhail NS
Am J Hematol; 2020 Jun; 95(6):672-690. PubMed ID: 32086970
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
[TBL] [Abstract][Full Text] [Related]
3. The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial.
Striha A; Ashcroft AJ; Hockaday A; Cairns DA; Boardman K; Jacques G; Williams C; Snowden JA; Garg M; Cavenagh J; Yong K; Drayson MT; Owen R; Cook M; Cook G
Trials; 2018 Mar; 19(1):169. PubMed ID: 29514706
[TBL] [Abstract][Full Text] [Related]
4. Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
Raje N; Faiman B; Harvey RD; Kurtin SE; Lonial S; Kumar SK; Cohen AD; Conde MA; Giralt SA; Recine MS; Tombler ER; Stadtmauer E; Jagannath S; Anderson KC;
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):356-69. PubMed ID: 25066040
[TBL] [Abstract][Full Text] [Related]
5. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging treatments for multiple myeloma.
Schwartz RN; Vozniak M
J Manag Care Pharm; 2008 Sep; 14(7 Suppl):12-9. PubMed ID: 18774881
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy and supportive care for patients with multiple myeloma.
Kyle RA
Semin Oncol; 1999 Oct; 26(5 Suppl 13):35-42. PubMed ID: 10528893
[TBL] [Abstract][Full Text] [Related]
8. panobinostat (FARYDAK°). Multiple myeloma: too toxic!
Prescrire Int; 2016 Nov; 25(176):257-259. PubMed ID: 30715819
[TBL] [Abstract][Full Text] [Related]
9. Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities.
Paner A; Okwuosa TM; Richardson KJ; Libby EN
Expert Rev Hematol; 2018 Dec; 11(12):957-973. PubMed ID: 30339769
[No Abstract] [Full Text] [Related]
10. Supportive Care in Multiple Myeloma.
Guzdar A; Costello C
Curr Hematol Malig Rep; 2020 Apr; 15(2):56-61. PubMed ID: 32172361
[TBL] [Abstract][Full Text] [Related]
11. Treatment of myeloma.
Smith ML; Newland AC
QJM; 1999 Jan; 92(1):11-4. PubMed ID: 10209667
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Scheid C; Sonneveld P; Schmidt-Wolf IG; van der Holt B; el Jarari L; Bertsch U; Salwender H; Zweegman S; Blau IW; Vellenga E; Weisel K; Pfreundschuh M; Jie KS; Neben K; van de Velde H; Duehrsen U; Schaafsma MR; Lindemann W; Kersten MJ; Peter N; Hänel M; Croockewit S; Martin H; Wittebol S; Bos GM; van Marwijk-Kooy M; Wijermans P; Goldschmidt H; Lokhorst HM
Haematologica; 2014 Jan; 99(1):148-54. PubMed ID: 23996482
[TBL] [Abstract][Full Text] [Related]
13. Young Adults with Multiple Myeloma.
Devine H; Verina D
Semin Oncol Nurs; 2017 Aug; 33(3):316-331. PubMed ID: 28712718
[TBL] [Abstract][Full Text] [Related]
14. Choosing treatment options for patients with relapsed/refractory multiple myeloma.
Castelli R; Orofino N; Losurdo A; Gualtierotti R; Cugno M
Expert Rev Anticancer Ther; 2014 Feb; 14(2):199-215. PubMed ID: 24329153
[TBL] [Abstract][Full Text] [Related]
15. Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
Faiman BM; Mangan P; Spong J; Tariman JD;
Clin J Oncol Nurs; 2011 Aug; 15 Suppl(Suppl):66-76. PubMed ID: 21816711
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy in multiple myeloma.
Mihelic R; Kaufman JL; Lonial S
Leukemia; 2007 Jun; 21(6):1150-7. PubMed ID: 17344913
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma and renal failure: one center's experience.
Magee C; Vella JP; Tormey WP; Walshe JJ
Ren Fail; 1998 Jul; 20(4):597-606. PubMed ID: 9713878
[TBL] [Abstract][Full Text] [Related]
18. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV
Blood; 2015 Mar; 125(13):2068-74. PubMed ID: 25628469
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed and refractory multiple myeloma.
Singhal S; Mehta J
Curr Treat Options Oncol; 2003 Jun; 4(3):229-37. PubMed ID: 12718800
[TBL] [Abstract][Full Text] [Related]
20. Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.
Huskey JL; Heilman RL; Khamash H; Fonseca R
Transplantation; 2018 Dec; 102(12):1994-2001. PubMed ID: 30211830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
